CN110234300B - 生物可吸收支架 - Google Patents

生物可吸收支架 Download PDF

Info

Publication number: CN110234300B
Authority: CN; China
Prior art keywords: stent; substantially linear; width; linear portion; cell
Prior art date: 2017-02-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

CN201880009013.1A

Other languages

English (en)

Chinese (zh)

Other versions

CN110234300A (zh

Inventor

清水一郎

和田晃

佐佐木诚

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

School Legal Person Plus Schoolgarden Okayama University Of Science

Japan Medical Device Technology Co Ltd

Original Assignee

School Legal Person Plus Schoolgarden Okayama University Of Science

Japan Medical Device Technology Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-02-01

Filing date

2018-01-29

Publication date

2021-04-06

2018-01-29 Application filed by School Legal Person Plus Schoolgarden Okayama University Of Science, Japan Medical Device Technology Co Ltd filed Critical School Legal Person Plus Schoolgarden Okayama University Of Science

2019-09-13 Publication of CN110234300A publication Critical patent/CN110234300A/zh

2021-04-06 Application granted granted Critical

2021-04-06 Publication of CN110234300B publication Critical patent/CN110234300B/zh

Status Active legal-status Critical Current

2038-01-29 Anticipated expiration legal-status Critical

Links

239000000463 material Substances 0.000 claims abstract description 28
239000000470 constituent Substances 0.000 claims abstract description 7
238000005304 joining Methods 0.000 claims description 17
229910000861 Mg alloy Inorganic materials 0.000 claims description 14
229910052751 metal Inorganic materials 0.000 description 31
239000002184 metal Substances 0.000 description 31
230000000052 comparative effect Effects 0.000 description 19
239000010935 stainless steel Substances 0.000 description 11
229910001220 stainless steel Inorganic materials 0.000 description 11
210000004204 blood vessel Anatomy 0.000 description 10
238000005452 bending Methods 0.000 description 9
238000012545 processing Methods 0.000 description 9
210000001367 artery Anatomy 0.000 description 8
238000005498 polishing Methods 0.000 description 8
239000003550 marker Substances 0.000 description 7
238000013461 design Methods 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
238000003698 laser cutting Methods 0.000 description 5
239000010410 layer Substances 0.000 description 5
229910052749 magnesium Inorganic materials 0.000 description 5
239000011777 magnesium Substances 0.000 description 5
208000031481 Pathologic Constriction Diseases 0.000 description 4
229920002988 biodegradable polymer Polymers 0.000 description 4
239000004621 biodegradable polymer Substances 0.000 description 4
210000004351 coronary vessel Anatomy 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
238000005259 measurement Methods 0.000 description 4
JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 3
230000017531 blood circulation Effects 0.000 description 3
230000007797 corrosion Effects 0.000 description 3
238000005260 corrosion Methods 0.000 description 3
238000002788 crimping Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
239000003814 drug Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
238000000034 method Methods 0.000 description 3
229920001610 polycaprolactone Polymers 0.000 description 3
239000004632 polycaprolactone Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
238000012360 testing method Methods 0.000 description 3
WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
229910000914 Mn alloy Inorganic materials 0.000 description 2
229920000954 Polyglycolide Polymers 0.000 description 2
WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical class [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
239000008151 electrolyte solution Substances 0.000 description 2
230000014509 gene expression Effects 0.000 description 2
230000003902 lesion Effects 0.000 description 2
229910052748 manganese Inorganic materials 0.000 description 2
150000002739 metals Chemical class 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012014 optical coherence tomography Methods 0.000 description 2
230000000704 physical effect Effects 0.000 description 2
229920001432 poly(L-lactide) Polymers 0.000 description 2
239000004633 polyglycolic acid Substances 0.000 description 2
208000037803 restenosis Diseases 0.000 description 2
230000036262 stenosis Effects 0.000 description 2
208000037804 stenosis Diseases 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
230000002792 vascular Effects 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
229910052725 zinc Inorganic materials 0.000 description 2
229910052726 zirconium Inorganic materials 0.000 description 2
206010003210 Arteriosclerosis Diseases 0.000 description 1
101100129922 Caenorhabditis elegans pig-1 gene Proteins 0.000 description 1
101100520057 Drosophila melanogaster Pig1 gene Proteins 0.000 description 1
HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
229910052779 Neodymium Inorganic materials 0.000 description 1
229910000990 Ni alloy Inorganic materials 0.000 description 1
HWBWPQJFPHMBHE-UHFFFAOYSA-N OCC(O)=O.O=C1OCCCO1 Chemical compound OCC(O)=O.O=C1OCCCO1 HWBWPQJFPHMBHE-UHFFFAOYSA-N 0.000 description 1
229930012538 Paclitaxel Natural products 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
229910001069 Ti alloy Inorganic materials 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
208000011775 arteriosclerosis disease Diseases 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000011247 coating layer Substances 0.000 description 1
230000008602 contraction Effects 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
229960005167 everolimus Drugs 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
239000000203 mixture Substances 0.000 description 1
229910052758 niobium Inorganic materials 0.000 description 1
229960001592 paclitaxel Drugs 0.000 description 1
229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
239000000622 polydioxanone Substances 0.000 description 1
238000003672 processing method Methods 0.000 description 1
230000010349 pulsation Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
230000002966 stenotic effect Effects 0.000 description 1
229910052715 tantalum Inorganic materials 0.000 description 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
238000002525 ultrasonication Methods 0.000 description 1
YYSFXUWWPNHNAZ-PKJQJFMNSA-N umirolimus Chemical compound C1[C@@H](OC)[C@H](OCCOCC)CC[C@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 YYSFXUWWPNHNAZ-PKJQJFMNSA-N 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1
CGTADGCBEXYWNE-JUKNQOCSSA-N zotarolimus Chemical compound N1([C@H]2CC[C@@H](C[C@@H](C)[C@H]3OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@@]4(O)[C@H](C)CC[C@H](O4)C[C@@H](/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C3)OC)C[C@H]2OC)C=NN=N1 CGTADGCBEXYWNE-JUKNQOCSSA-N 0.000 description 1
229950009819 zotarolimus Drugs 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91583—Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Surgery (AREA)
Transplantation (AREA)
Optics & Photonics (AREA)
Oral & Maxillofacial Surgery (AREA)
Cardiology (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Composite Materials (AREA)
Materials Engineering (AREA)
Media Introduction/Drainage Providing Device (AREA)

CN201880009013.1A 2017-02-01 2018-01-29 生物可吸收支架 Active CN110234300B (zh)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2017-017130		2017-02-01
JP2017017130		2017-02-01
PCT/JP2018/002669 WO2018143115A1 (ja)	2017-02-01	2018-01-29	生体吸収性ステント

Publications (2)

Publication Number	Publication Date
CN110234300A CN110234300A (zh)	2019-09-13
CN110234300B true CN110234300B (zh)	2021-04-06

Family

ID=63039777

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN201880009013.1A Active CN110234300B (zh)	2017-02-01	2018-01-29	生物可吸收支架

Country Status (6)

Country	Link
US (1)	US11135075B2 (ja)
EP (1)	EP3578142B1 (ja)
JP (1)	JP6628263B2 (ja)
CN (1)	CN110234300B (ja)
AU (1)	AU2018214780B2 (ja)
WO (1)	WO2018143115A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3708129A1 (de) *	2019-03-15	2020-09-16	Biotronik Ag	Implantat
CN110974486A (zh) *	2019-12-04	2020-04-10	金仕生物科技（常熟）有限公司	人工瓣膜输送装置

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1212986A1 (en) *	2000-12-08	2002-06-12	SORIN BIOMEDICA CARDIO S.p.A.	An angioplasty stent and manufacturing method thereof
US6613079B1 (en) *	1998-02-05	2003-09-02	Medtronic, Inc.	Radially-expandable stent with controllable force profile
ES2207407A1 (es) *	2002-11-05	2004-05-16	Iberhospitex, S.A.	Stent recubierto con estatinas para la administracion a un paciente.
CN202568545U (zh) *	2012-02-01	2012-12-05	内蒙古工业大学	一种冠脉支架
JP2013539661A (ja) *	2010-09-13	2013-10-28	メリルライフサイエンシズピーブィティ．エルティディ	薄ストラット厚および可変ストラット形状を有するステント
CN104921854A (zh) *	2015-06-12	2015-09-23	上海君联医疗设备有限公司	一种可吸收血管支架及其制备方法
WO2016037115A1 (en) *	2014-09-04	2016-03-10	Boston Scientific Scimed, Inc.	Bioerodible polymeric stent scaffolding pattern

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5776161A (en) *	1995-10-16	1998-07-07	Instent, Inc.	Medical stents, apparatus and method for making same
US6451049B2 (en) *	1998-04-29	2002-09-17	Sorin Biomedica Cardio, S.P.A.	Stents for angioplasty
JP3654627B2 (ja)	2000-04-20	2005-06-02	川澄化学工業株式会社	ステント
US20050080479A1 (en) *	2003-09-29	2005-04-14	Feng James Q.	Expandable endovascular stent
US7060090B2 (en) *	2003-10-15	2006-06-13	Medtronic Vascular, Inc.	Stent with increased longitudinal flexibility and scaffolding
US7731890B2 (en) *	2006-06-15	2010-06-08	Advanced Cardiovascular Systems, Inc.	Methods of fabricating stents with enhanced fracture toughness
US7309353B2 (en) *	2005-04-29	2007-12-18	Medtronic Vascular, Inc.	Use of platinum group metals in vascular devices and method of texturing platinum group metals
US20070135899A1 (en)	2005-12-13	2007-06-14	Robert Burgermeister	Polymeric stent having modified molecular structures in the flexible connectors and the radial struts of the hoops
CA2652753C (en)	2006-05-12	2015-12-08	Cordis Corporation	Balloon expandable bioabsorbable drug eluting stent
US20070282433A1 (en) *	2006-06-01	2007-12-06	Limon Timothy A	Stent with retention protrusions formed during crimping
US8974514B2 (en)	2007-03-13	2015-03-10	Abbott Cardiovascular Systems Inc.	Intravascular stent with integrated link and ring strut
JP3145720U (ja)	2008-08-06	2008-10-16	株式会社日本ステントテクノロジー	ステント
CN102497838A (zh)	2009-09-17	2012-06-13	株式会社日本斯滕特技术	支架
JP6349588B2 (ja)	2012-04-11	2018-07-04	クリノ株式会社	ステントの製造方法
EP2710984B1 (en)	2012-09-19	2015-08-26	Biotronik AG	Implant and system formed of a balloon catheter and implant
US10271975B2 (en) *	2013-03-15	2019-04-30	Atrium Medical Corporation	Stent device having reduced foreshortening and recoil and method of making same
JP2015154925A (ja) *	2014-01-17	2015-08-27	株式会社日本ステントテクノロジー	耐食性に優れたステント
WO2016110875A1 (en) *	2015-01-07	2016-07-14	Sahajanand Medical Technologies Private Limited	Endoluminal stent
JP6558569B2 (ja) *	2015-05-21	2019-08-14	ニプロ株式会社	ステント
US10758384B2 (en) *	2016-07-13	2020-09-01	Cook Medical Technologies Llc	Stent having reduced foreshortening
CA3143738A1 (en) *	2019-06-25	2020-12-30	Atrium Medical Corporation	Stent device including a flarable crown

2018
- 2018-01-29 EP EP18748044.7A patent/EP3578142B1/en active Active
- 2018-01-29 WO PCT/JP2018/002669 patent/WO2018143115A1/ja not_active Ceased
- 2018-01-29 AU AU2018214780A patent/AU2018214780B2/en not_active Ceased
- 2018-01-29 CN CN201880009013.1A patent/CN110234300B/zh active Active
- 2018-01-29 JP JP2018565523A patent/JP6628263B2/ja active Active
2019
- 2019-07-29 US US16/525,123 patent/US11135075B2/en active Active

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6613079B1 (en) *	1998-02-05	2003-09-02	Medtronic, Inc.	Radially-expandable stent with controllable force profile
EP1212986A1 (en) *	2000-12-08	2002-06-12	SORIN BIOMEDICA CARDIO S.p.A.	An angioplasty stent and manufacturing method thereof
ES2207407A1 (es) *	2002-11-05	2004-05-16	Iberhospitex, S.A.	Stent recubierto con estatinas para la administracion a un paciente.
JP2013539661A (ja) *	2010-09-13	2013-10-28	メリルライフサイエンシズピーブィティ．エルティディ	薄ストラット厚および可変ストラット形状を有するステント
CN202568545U (zh) *	2012-02-01	2012-12-05	内蒙古工业大学	一种冠脉支架
WO2016037115A1 (en) *	2014-09-04	2016-03-10	Boston Scientific Scimed, Inc.	Bioerodible polymeric stent scaffolding pattern
CN104921854A (zh) *	2015-06-12	2015-09-23	上海君联医疗设备有限公司	一种可吸收血管支架及其制备方法

Also Published As

Publication number	Publication date
JPWO2018143115A1 (ja)	2019-11-07
AU2018214780B2 (en)	2022-02-03
AU2018214780A1 (en)	2019-08-15
WO2018143115A1 (ja)	2018-08-09
US20190350732A1 (en)	2019-11-21
EP3578142B1 (en)	2022-03-23
EP3578142A4 (en)	2020-11-25
CN110234300A (zh)	2019-09-13
EP3578142A1 (en)	2019-12-11
JP6628263B2 (ja)	2020-01-08
US11135075B2 (en)	2021-10-05

Publication	Publication Date	Title
US10687967B2 (en)	2020-06-23	Stretchable stent and delivery system
US9603733B2 (en)	2017-03-28	Highly flexible stent
EP2063824B1 (en)	2020-10-28	Helical implant having different ends
JP5243577B2 (ja)	2013-07-24	生体内留置用ステント
US9056351B2 (en)	2015-06-16	Stent with improved flexibility and method for making same
EP2763629B1 (en)	2019-02-20	Reduced wire profile stent
JP4928813B2 (ja)	2012-05-09	生体内留置用ステント
WO2002005863A1 (en)	2002-01-24	Radiopaque stent composed of a binary alloy
CA2601854A1 (en)	2006-10-05	Endoprostheses
US10463513B2 (en)	2019-11-05	Biodegradable metallic vascular stent and application thereof
CN110234300B (zh)	2021-04-06	生物可吸收支架
US7651524B2 (en)	2010-01-26	Flexible stent
JP4928891B2 (ja)	2012-05-09	自己拡張型生体内留置用ステント
US9700441B2 (en)	2017-07-11	Devices and methods related to deposited support structures
US20180133034A1 (en)	2018-05-17	Non-circular radiopaque markers and methods for attaching a marker to a scaffold
WO2007040249A1 (ja)	2007-04-12	生体留置用ステント
JP2005287568A (ja)	2005-10-20	ステント
US20220346988A1 (en)	2022-11-03	Stent
JP5267457B2 (ja)	2013-08-21	ステント
JP2005287567A (ja)	2005-10-20	ステント
JP2017094017A (ja)	2017-06-01	ステント
US20110251672A1 (en)	2011-10-13	Aspect ratio for stent strut design

Legal Events

Date	Code	Title
2019-09-13	PB01	Publication
2019-09-13	PB01	Publication
2019-10-15	SE01	Entry into force of request for substantive examination
2019-10-15	SE01	Entry into force of request for substantive examination
2021-04-06	GR01	Patent grant
2021-04-06	GR01	Patent grant